A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors
Clinical trial NCT02099058 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02099058
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-15
- Primary completion
- 2026-08-01
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.